EC published the Delegated Regulation (EU) 2019/981 that amends the Regulation (EU) 2015/35, which supplements Solvency II Directive (2009/138/EC) on the taking-up and pursuit of the business of insurance and reinsurance. These new rules under Solvency II will make it easier for insurers to provide financing to companies, including small and medium enterprises (SMEs). Regulation (EU) 2019/981 shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. Points (50), (59) to (61), (66) and (74) of Article 1 of Regulation (EU) 2019/981 shall apply from January 01, 2020.
The current level of capital requirements makes it costly for insurers to finance SMEs, particularly in the case of long-term equity investments and private debt. Insurers providing finance via such instruments, which should help mobilize private-sector investment, is a key objective of the Capital Markets Union. Regulation (EU) 2019/981 introduces simplifications for the calculation of capital requirements by insurance companies as well as alignments between rules for banking and the insurance sector. This will reduce the regulatory burden for insurers without jeopardizing the safety of the sector. Further revisions of technical nature in the delegated regulation ensure that the rules remain fit for purpose. A more fundamental review of Solvency II is due by the end of 2020. Preparatory work for that review is ongoing. In line with the objectives of the Capital Markets Union, further analysis on remaining obstacles to investments in the real economy will be undertaken.
Effective Date: July 08, 2019
Keywords: Europe, EU, Insurance, Securities, Solvency II, Capital Requirements, Capital Markets Union, Regulation 2019/981, Regulation 2015/35, SCR, EC
APRA has concluded its review of the comprehensive plans of authorized deposit-taking institutions for the assessment and management of loans with repayment deferrals.
ESAs (EBA, EIOPA, and ESMA) published the first joint report that assesses risks in the financial sector since the outbreak of the COVID-19 pandemic.
BoE and HM Treasury confirmed that the COVID Corporate Financing Facility (CCFF) will close for new purchases of commercial paper, with effect from March 23, 2021.
ECB published a decision allowing the euro area banks under its direct supervision to exclude certain central bank exposures from the leverage ratio.
ESAs launched a survey seeking feedback on the presentational aspects of product templates under the Sustainable Finance Disclosure Regulation (SFDR or Regulation 2019/2088).
ECB published input of the European System of Central Banks (ESCB) into the EBA feasibility report on reducing the reporting burden for banks in EU.
EC adopted a decision determining, for a limited period of time, that the regulatory framework applicable to central counterparties, or CCPs, in the UK and Northern Ireland is equivalent to the requirements laid down in the European Market Infrastructure Regulation (EMIR or Regulation 648/2012).
EBA has decided to phase out the guidelines on legislative and non-legislative moratoria of loan repayments, in accordance with the earlier specified end of September deadline.
EBA published an Opinion addressed to EC to raise awareness about the opportunity to clarify certain issues related to the definition of credit institution in the upcoming review of the Capital Requirements Directive and Regulation (CRD and CRR).
ECB finalized the guide on assessment methodology for the internal model method for calculating exposure to counterparty credit risk (CCR) and the advanced method for own funds requirements for credit valuation adjustment (A-CVA) risk.